General Electric

Cytiva Opens Swiss Cell and Gene Therapy Center

Cytiva, the former biopharma activities of General Electric and now part of Danaher, will open a new manufacturing facility in Grens, Switzerland, on May 31. Operations at the existing site in Eysins will continue through 2023, while full production transfers to the Grens site.

GE Healthcare Set to become a Standalone Company

Under a tax-free scheme, General Electric (GE) is officially carving out its healthcare business into a standalone company. The move that had been expected to take place several times over the past three years but repeatedly stalled is now set to be completed in early 2023. The US conglomerate plans to retain a stake of just under 20%.

Environment Rollback Roils America

Investor Seeks to Nominate Candidates to DuPont Board

Fracking With CO2 to Replace Water a Distant Goal, Says GE

Oil- and Gas-Field Chemicals

Bahrain: Bringing Innovation and Industrialization to Life

GE Drops Legal Fight Over Running Tar Sands Megaloads On Idaho Highway

General Electric Names New Head of Oil and Gas Unit

General Electric: Olympics Bring $100 Million in Sales

Samsung LED Launches Patent Countersuit Against Osram

Jeff Immelt Shifting GE's Focus To Buybacks From Takeovers

GE Unlikely To Face Liability in Japanese Nuclear Crisis

EPA Orders GE to Do More to Clean Hudson River

Roundup: Deals of the Day

Oil Spill Boosts Shares of Recovery Companies